Brittani Cushman - 03 Feb 2022 Form 4 Insider Report for Turning Point Brands, Inc. (TPB)

Role
Sr VP, General Counsel
Signature
/s/ Brittani Cushman
Issuer symbol
TPB
Transactions as of
03 Feb 2022
Net transactions value
$0
Form type
4
Filing time
03 May 2022, 17:13:24 UTC
Previous filing
29 Oct 2021
Next filing
16 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding TPB Common Stock 6,015 03 Feb 2022 Direct F10
holding TPB Common Stock 407 03 Feb 2022 By Spouse F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TPB Dividend Equivalent Right Award $0 +107 $0.000000 107 03 Feb 2022 Common Stock 107 Direct F11, F12
transaction TPB Dividend Equivalent Right Disposed to Issuer -107 -100% 0 29 Apr 2022 Common Stock 107 Direct F11, F13
holding TPB Options (2022) 8,000 03 Feb 2022 Common Stock 8,000 $30.46 Direct F8, F9
holding TPB Options (2021) 7,000 03 Feb 2022 Common Stock 7,000 $51.75 Direct F2, F3
holding TPB Options (2020) 6,000 03 Feb 2022 Common Stock 6,000 $14.85 Direct F2, F4
holding TPB Options (2019) 4,800 03 Feb 2022 Common Stock 4,800 $47.58 Direct F2, F5
holding TPB Options (2018) 4,500 03 Feb 2022 Common Stock 4,500 $21.21 Direct F2, F6
holding TPB Options (2017) 3,250 03 Feb 2022 Common Stock 3,250 $15.41 Direct F2, F7
holding TPB Options (2017) 20,000 03 Feb 2022 Common Stock 20,000 $13.00 Direct F2, F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person disclaims beneficial ownership of these securities, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership for purposes of Section 16 or for any other purpose.
F2 Granted pursuant to the issuer's 2015 Equity Incentive Plan
F3 The options vest and become exercisable as to 34% of the underlying shares on January 1, 2022, 33% of the underlying shares on January 1, 2023 and 33% of the underlying shares on January 1, 2024.
F4 The options vest and become exercisable as to 34% of the underlying shares on January 1, 2021, 33% of the underlying shares on January 1, 2022 and 33% of the underlying shares on January 1, 2023.
F5 The options vest and become exercisable as to 34% of the underlying shares on January 1, 2020, 33% of the underlying shares on January 1, 2021 and 33% of the underlying shares on January 1, 2022.
F6 The options vest and become exercisable as to 34% of the underlying shares on January 1, 2019, 33% of the underlying shares on January 1, 2020 and 33% of the underlying shares on January 1, 2021.
F7 The options vest and become exercisable as to 34% of the underlying shares on January 1, 2018, 33% of the underlying shares on January 1, 2019 and 33% of the underlying shares on January 1, 2020.
F8 The options vest and become exercisable as to 34% of the underlying shares on January 1, 2023, 33% of the underlying shares on January 1, 2024 and 33% of the underlying shares on January 1, 2025.
F9 Granted pursuant to the issuer's 2021 Equity Incentive Plan.
F10 The total reported in Column 5 includes 2,500 awarded restricted stock units and 3,515 shares of common stock.
F11 Each dividend equivalent right was the economic equivalent of one share of the Company's common stock.
F12 In connection with the vesting and settlement of previously-granted performance-based restricted stock units, which settled in shares of the Company's common stock on February 3, 2022, the reporting person acquired 107 fully-vested dividend equivalent rights pursuant to the terms of the applicable award agreement.
F13 On April 29, 2022, the dividend equivalent rights were disposed of and cancelled in exchange for a cash payment equal to $3,610.42